Article Details
Retrieved on: 2022-05-27 20:20:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SEATTLE, May 27, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) today announced that an authorized subcommittee of the Compensation ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here